-去背.png){kind=logo}
News
-
artiCure and TFBS Bioscience Join Forces in Virus Manufacturing to Advance Development of Innovative Cancer Gene Therapy
2025-08-28 artiCure and TFBS Bioscience Join Forces in Virus Manufacturing to Advance Development of Innovative Cancer Gene Therapy Korea’s innovative cancer therapy company artiCure and leading viral vector manufacturer from Taiwan, TFBS Bioscience Inc. jointly announce the collaboration on GMP manufacturing of retroviral vectors, aiming to accelerate clinical trials of cancer gene therapy in Korea. Learn more -
TFBS Bioscience and U-Medico Announce Strategic Alliance to Launch GMP QC Testing Services for CGT therapeutics
2025-08-28 TFBS Bioscience and U-Medico Announce Strategic Alliance to Launch GMP QC Testing Services for CGT therapeutics TFBS Bioscience Inc., a Taiwan and Japan-based company offering total solutions for GMP manufacturing of viral vector and U-Medico Inc., a leading Japanese company providing advanced analytical solutions, today announced a strategic partnership to jointly launch a new suite of Good Manufacturing Practice (GMP) Quality Control (QC) testing services. This collaboration marks a significant milestone in international cooperation, aiming at delivering accurate, regulatory-compliant QC testing services for viral vectors across Japan, Taiwan, and the broader Asia-Pacific region. Learn more -
AAVnerGene and TFBS Bioscience Announce Collaboration to Develop Innovative AAV Vector Technology Platform for Gene Therapy
2025-07-16 AAVnerGene and TFBS Bioscience Announce Collaboration to Develop Innovative AAV Vector Technology Platform for Gene Therapy AAVnerGene Inc. and TFBS Bioscience Inc. today announced a collaboration on the development and application of innovative adeno-associated virus (AAV) vector technologies for manufacturing, including key areas such as AAV tropism enhancement and manufacturing process optimization. Learn more
